Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 7, 2018Biology of Blood and Marrow TransplantationOpen Access

Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis

View Full Paper
Ask AI
Bookmark
Share

Authors

MSM Hasib SidiqiBentley UniversityFBFrancis K. BuadiMayo ClinicAngela DispenzieriAngela DispenzieriBoston University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sidiqi et al. (2018) studied this question.

synapsesocial.com/papers/6a8239c2a7f499675bc6a34ehttps://doi.org/10.1016/j.bbmt.2018.12.003
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine2018 · 33 citations
  2. 2Clinical presentation and treatment responses in IgM-related AL amyloidosis2015 · 24 citations
  3. 3Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements2012 · 1,149 citations
  4. 4Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis2005 · 1,436 citations
  5. 5Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time2018 · 128 citations